Risk factors for hematological toxicity of chemotherapy for bone and soft tissue sarcoma
نویسندگان
چکیده
منابع مشابه
Risk factors for hematological toxicity of chemotherapy for bone and soft tissue sarcoma
The aim of this study was to assess chemotherapy treatment characteristics, neutropenic event occurrence and related risk factors in bone and soft tissue sarcoma patients in China. Knowledge of such risk factors aids healthcare providers in focusing resources on those who are at most risk and targeting prophylactic colony-stimulating factors (CSFs) for those patients. The study included 113 chi...
متن کاملHistology-driven chemotherapy of soft-tissue sarcoma.
Soft-tissue sarcomas are rare diseases with >50 subtypes. Surgery is the most important treatment in localized disease, sometimes combined with radiotherapy. Chemotherapy is used as palliation in advanced disease, sometimes also with a potential to decrease tumour size and eradicate micro-metastases, making meaningful surgery possible. The role of chemotherapy as adjuvant treatment in localized...
متن کاملMetastatic soft tissue sarcoma chemotherapy: an opportunity for personalized medicine.
BACKGROUND Soft tissue sarcoma (STS) includes biologically and histologically diverse mesenchymal tumors that are relatively chemotherapy-resistant compared with other sarcoma subtypes. METHODS The authors discuss the clinical challenges frequently encountered by medical oncologists and review the literature for predictive strategies to systematically approach chemotherapy decision making. ...
متن کاملMajor wound complication risk factors following soft tissue sarcoma resection.
BACKGROUND AND OBJECTIVES Wound-healing complications represent an important source of morbidity in patients treated surgically for soft tissue sarcomas (STS). The purpose of this study was to determine which factors are predictive of major wound complication rates following STS resection, including tumor site, size, grade, and depth, as well as radiotherapy and chemotherapy. METHODS We revie...
متن کاملneoadjuvant chemotherapy with ifosfamide, cisplatin, adriamycin and mitomycin (imap) for high risk adult soft tissue sarcomas
to define efficacy of pre-operative chemotherapy in down staging of advanced non-round cell soft tissue sarcomas. from sep 2002 to dec 2005, 70 patients were treated by ifosfamid, mesna, cisplatin, adriamycin, mitomycin and subsequent surgery. postoperatively, patients received radiotherapy in cases of microscopically incomplete resection or local recurrence. the median age of the patients was ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Oncology Letters
سال: 2013
ISSN: 1792-1074,1792-1082
DOI: 10.3892/ol.2013.1234